Company Update ALEMBIC PHARMACEUTICALS LTD. - 533573 - Completion Of USFDA Inspection At Alembic Pharmaceuticals Limited'S Bioequivalence Facility … BSE India We would like to inform the exchange that the USFDA has conducted an inspection at our Bioequivalence Facility located at Vadodara from 3rd March, 2025 to 7th March, 2025. The USFDA has issued a Form 483 with one procedural observation.